Literature DB >> 18245481

ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.

Liqun Yin1, Paola Castagnino, Richard K Assoian.   

Abstract

We describe here the regulation of ABCG2 expression and side population (SP) abundance in MCF7 human breast cancer cells. The level of ABCG2 mRNA and protein were increased in purified MCF7 SP relative to non-SP cells, and incubation with an ABCG2-specific inhibitor or ABCG2 short interfering RNA eliminated the MCF7 SP. The purified MCF7 SP could generate a heterogeneous population containing both SP and non-SP cells in culture. In vivo tumorigenicity experiments showed that the purified MCF7 SP has an increased ability to colonize the mouse mammary gland. Importantly, the MCF7 SP was depleted by a transforming growth factor-beta (TGFbeta)-directed epithelial-mesenchymal transition (EMT), and this effect was associated with a strong down-regulation of ABCG2 gene expression, and an increased sensitivity to mitoxantrone. ABCG2 expression and SP abundance were restored upon the removal of transforming growth factor-beta and reversion of the cells to an epithelial phenotype. Knock-down of E-cadherin also reduced SP abundance, but this effect was not accompanied by the loss of ABCG2 mRNA or protein. We conclude that ABCG2 expression in MCF7 cells is regulated during an EMT, and that the EMT effect reflects posttranslational regulation of ABCG2 function by E-cadherin as well as transcriptional repression of the ABCG2 gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245481     DOI: 10.1158/0008-5472.CAN-07-2545

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?

Authors:  Tetyana V Bagnyukova; Ilya G Serebriiskii; Yan Zhou; Elizabeth A Hopper-Borge; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

2.  Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.

Authors:  Sebastian C J Steiniger; Judith A Coppinger; Jörg A Krüger; John Yates; Kim D Janda
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

Review 3.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 4.  Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.

Authors:  Tong Chen; Yanan You; Hua Jiang; Zack Z Wang
Journal:  J Cell Physiol       Date:  2017-04-10       Impact factor: 6.384

5.  Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.

Authors:  Janet Morgan; Jennifer D Jackson; Xiang Zheng; Suresh K Pandey; Ravindra K Pandey
Journal:  Mol Pharm       Date:  2010-09-01       Impact factor: 4.939

6.  Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.

Authors:  Xin-xing Li; Ying Dong; Wei Wang; Hao-lu Wang; Yu-ying Chen; Gui-ying Shi; Jing Yi; Jian Wang
Journal:  Stem Cells Dev       Date:  2012-11-07       Impact factor: 3.272

Review 7.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

8.  hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations.

Authors:  F Wang; X Xue; J Wei; Y An; J Yao; H Cai; J Wu; C Dai; Z Qian; Z Xu; Y Miao
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

Review 9.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

10.  Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.

Authors:  Charlotte Bell; Claire Hill; Christopher Burton; Adam Blanchard; Freya Shephard; Cyril Rauch
Journal:  Cell Biochem Biophys       Date:  2013-07       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.